Microbot Medical, Inc. Common Stock

MBOT

Microbot Medical, Inc. is a medical device company focused on developing innovative robotic and microservice solutions for minimally invasive procedures. The company’s technology aims to improve patient outcomes by enabling enhanced precision, safety, and ease of use in various interventional healthcare applications.

$1.75 +0.00 (0.13%)
🚫 Microbot Medical, Inc. Common Stock does not pay dividends

Company News

MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value
Benzinga • Equity Insider • March 27, 2026

The healthcare sector is shifting toward outpatient clinics and ambulatory services, with AI-powered diagnostics and remote care technologies gaining significant traction. Multiple medtech companies are advancing innovative solutions: VentriPoint Diagnostics is expanding cardiac imaging to remote communities via partnership with First Light Healt...

Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event
GlobeNewswire Inc. • Na • March 3, 2026

Microbot Medical announced that its operations in the USA and Israel remain unaffected by current geopolitical events. The company is proceeding with its commercial expansion of the LIBERTY Endovascular Robotic System, including hiring additional sales representatives and a Director of HEOR. The company plans a full market release at the Society ...

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
GlobeNewswire Inc. • Microbot Medical Inc. • October 7, 2025

Microbot Medical completed a three-tranche preferred investment option exercise, raising approximately $29.2 million in gross proceeds, with potential additional proceeds of $63 million from future option exercises.

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
GlobeNewswire Inc. • Microbot Medical Inc. • September 16, 2025

Microbot Medical raised $25.2 million in the first closing of a preferred investment option exercise, with potential additional gross proceeds of up to $92.2 million. The company plans to use the funds for developing its LIBERTY Robotic System, potential acquisitions, and general corporate purposes.

Microbot Medical Closes $13 Million Registered Direct Offering
GlobeNewswire Inc. • Microbot Medical Inc. • February 11, 2025

Microbot Medical Inc. announced the closing of a registered direct offering and concurrent private placement, raising approximately $13 million. The company plans to use the proceeds for the development, commercialization, and regulatory activities of its LIBERTY® Robotic System, as well as for working capital and other general corporate purposes.

Related Companies